ALB and pancreatic neoplasm: Drug treatment promoted eosinophils in pancreatic cancer patients (p = 0.015), increased potassium (p = 0.013), and decreased albumin (p = 0.016) in CRC patients; however, these effects did not remain significant after false discovery rate (FDR) correction.